The US Food and Drug Administration (FDA) has approved dasiglucagon (Zegalogue 0.6 mg/0.6 mL, Zealand Pharma) autoinjector and prefilled syringe for the treatment of severe hypoglycemia in people with ...

Gvoke (glucagon) is a prescription drug that’s used to treat severely low blood sugar in certain people with diabetes. Gvoke comes as a liquid solution that’s given as an injection under the skin.

Lupin has received approval from the Food and Drug Administration for liraglutide injection single-patient-use prefilled pens and glucagon for injection vials. Both of these products will be ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...

When a person with Type 1 diabetes develops severe hypoglycemia (more commonly known as low blood sugar), they turn to glucagon. This hormone, produced in limited quantities by the pancreas, orders ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for someone ...

When using glucagon-like peptide-1 drugs (GLP-1s) for weight loss or diabetes, you need to get comfortable with injecting the medication under your skin (subcutaneously). Typically, you will target ...

Sustaining healthy weight loss is about much more than cutting calories or injecting drugs, as many glucagon-like peptide-1 ...

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA ...